Skip to content

BNR

Burning Rock Biotech Limited

NASDAQ · CNHealthcareMedical - Diagnostics & Research
$10.07+1.00%

Price as of Jul 20, 2026

BNR capital

Burning Rock Biotech Limited capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.10x
Net debt / equity
-0.77x
Debt / assets
0.06x
Debt / EBITDA
-2.20x
Net debt / EBITDA
17.10x

Liquidity & coverage

Current ratio
3.05x
Quick ratio
2.81x
Cash ratio
1.94x
Interest coverage
EBITDA / interest
-513.36x
Working capital
$69.6M

Cash & dividend

FCF / debt
-0.78x
Cash flow / debt
-0.67x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.